Utilize este identificador para referenciar este registo: https://hdl.handle.net/10216/149470
Registo completo
Campo DCValorIdioma
dc.creatorBhering, M-
dc.creatorSarubbi Junior, V-
dc.creatorKritski, A-
dc.creatorSouza, FBA-
dc.creatorDuarte, R-
dc.date.accessioned2023-05-23T14:23:13Z-
dc.date.available2023-05-23T14:23:13Z-
dc.date.issued2020-
dc.identifier.issn2504-3137-
dc.identifier.issn2504-3145-
dc.identifier.urihttps://hdl.handle.net/10216/149470-
dc.description.abstractIntroduction: The increase in drug-resistant tuberculosis (TB) threatens global progress in eliminating TB, and constitutes a major challenge for patients, health-care workers and health services. Treatment for multidrug-resistant TB (MDR-TB) can last almost 2 years, and is more expensive, more toxic, and less effective than treating TB caused by drug-sensitive bacilli. This study aims to analyze patients’ narratives about the challenges they face during MDR-TB treatment and identify the support factors that help patients being treated in the most populous district of Portugal. Methods: Semi-structured interviews were conducted with patients being treated for MDR-TB. The interviews were coded using thematic analysis. They were audio-recorded, transcribed, and transported into NVivo v12 for data management and coding. Results: Depression, social discrimination, and the side effects of drugs are the main challenges faced by patients with MDR-TB. A good relationship of the patients with the health team, emotional support, and supervised treatment stand out as the factors that generate better adherence and treatment success. Conclusion: In addition to modern diagnostic techniques and new treatments, MDR-TB can be fought by focusing on the care and needs of patients. We suggest that the Lisbon Tuberculosis Program adopts the following measures: build the health-care team’s capacity to identify symptoms of depression early, increase public awareness of the disease, expand the multidisciplinary team, and expand the options for individualized social support for patients.-
dc.language.isoeng-
dc.publisherKarger Publishers-
dc.relation.ispartofPort J Public Health 2020;38:62–70-
dc.rightsopenAccess-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectTuberculose-
dc.subjectTuberculose multirresistente-
dc.subjectInvestigação qualitativa-
dc.subjectEstigma social-
dc.subjectAvaliação de necessidades-
dc.subjectRelação profissional-doente-
dc.subjectAssistência ao paciente-
dc.subjectApoio social-
dc.titleMultidrug-Resistant Tuberculosis in Portugal: Patients' Perception of the Challenges Faced during Treatment-
dc.typeArtigo em Revista Científica Internacional-
dc.contributor.uportoInstituto de Saúde Pública da Universidade do Porto-
dc.identifier.doi10.1159/000511198-
dc.relation.publisherversionhttps://www.karger.com/Article/FullText/511198-
Aparece nas coleções:ISPUP - Artigo em Revista Científica Internacional

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
bhering-pjph-2021.pdf263.9 kBAdobe PDFThumbnail
Ver/Abrir


Este registo está protegido por Licença Creative Commons Creative Commons